It modulates circadian genes (PER2, CRY2), reduces inflammation, and inhibits pro-inflammatory cytokines (IL-6, TNF-α), highlighting its therapeutic potential in RA-ILD (98, 99). The gene discussed is TNF; the disease is rheumatoid arthritis.